Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: a prospective experience at an Italian center

Acta Haematol. 2011;126(1):1-7. doi: 10.1159/000323713. Epub 2011 Mar 11.

Abstract

Data derived from epidemiologic surveillance adopted at our center in hematologic and stem cell transplant patients during the 2009 influenza A (H1N1)v pandemic are reported. Of the 52 patients with influenza-like disease we observed, 37 underwent a real-time PCR evaluation and 21 had a confirmed diagnosis. Of the RT-PCR-confirmed cases, 23.8% were children (age <18 years) and 9.5% were >65 years; 47.6% presented with a pulmonary infiltrate and 33.3% with respiratory failure. Pulmonary involvement was observed more frequently in patients with comorbidities. All patients received a course of oseltamivir therapy starting an average of 1 day (range <1-2) after the onset of symptoms. No patient was transferred to the intensive care unit. The viral disease had a generally favorable outcome despite the high frequency of pulmonary involvement. A prompt clinical evaluation with an early antiviral and supportive therapy may have played a beneficial role in the outcome.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antiviral Agents / therapeutic use
  • Child
  • Child, Preschool
  • Female
  • Hematologic Diseases / complications*
  • Humans
  • Influenza, Human / complications
  • Influenza, Human / epidemiology*
  • Influenza, Human / therapy
  • Influenza, Human / virology
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Oseltamivir / therapeutic use
  • Polymerase Chain Reaction
  • Prospective Studies
  • Young Adult

Substances

  • Antiviral Agents
  • Oseltamivir